AVANOS CRKA-17-75-4Recalls & reported problems
Avanos Medical, Inc. · CRKA-17-75-4 AVNS,RF,RFQKIT,,-,1 · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00193493478828), received between Sep 23, 2026 and Sep 23, 2026 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Fever1
- Fluid Discharge1
- Pain1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 23, 2026Adverse Event Without Identified Device or Use Problem
It was reported "the day after the Coolief procedure, the patient experienced pain, warmth, and increased effusion in the left knee, raising suspicion of an infection. Blood was observed in the synovial fluid; however, no accumulation of pus was identified. The procedure was performed using aseptic technique."The patient underwent a bilateral COOLIEF procedure on (b)(6) 2026. The patient developed left knee pain one day after the procedure and right knee pain two days after the procedure.The reported symptoms included pain and warmth in the left knee with a slight increase in the pre-existing knee effusion. Information regarding pain severity, erythema, fever, or other signs of infection was not available.A joint aspiration and synovial fluid examination were performed approximately three days post-procedure. The aspirated fluid reportedly contained calcium pyrophosphate crystals, and the fluid appearance was described as approximately 50% blood-tinged, with no evidence of pus accumulation.Based on the clinical presentation and synovial fluid findings, the treating physician diagnosed the event as a pseudogout attack and indicated that there was no causal relationship to the COOLIE
Patient problems: Fever; Fluid Discharge; Pain
MAUDE report 50872977 ↗
Other Probe, radiofrequency lesion devices
- NA TCN-15Boston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION2 recalls10 reports
- NA TCN-10-3MBoston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION2 recalls9 reports
- NA CSK-TC10Boston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION1 recall1 death58 reports
- NA CLASSICSt. Jude Medical, Inc. · PROBE, RADIOFREQUENCY LESION1 recall40 reports
- Intracept RLV 0055Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall30 reports
- Intracept RLV 0045Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall1 death23 reports
- Intracept RLV0065Relievant Medsystems, Inc. · Probe, Radiofrequency Lesion1 recall14 reports
- NA CSK-TC5Boston Scientific Neuromodulation Corporation · PROBE, RADIOFREQUENCY LESION1 recall3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page